Table of Contents

company-logo

SillaJen, Inc. engages in the development and commercialization of oncolytic immunotherapy products. The company's lead product is Pexa-Vec, which is in Phase II clinical trial for the treatment of advanced liver cancer. It also develops JX-970 for the treatment of tumor tissues; and JX-900 is a series of modified vaccinia vaccine. The company was founded in 2006 and is headquartered in Seoul, South Korea.

SillaJen Dividend Announcement

• SillaJen does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on SillaJen dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

SillaJen Dividend History

SillaJen Dividend Yield

SillaJen current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing SillaJen stock? Use our calculator to estimate your expected dividend yield:

SillaJen Financial Ratios

P/E ratio-11.57
PEG ratio0.07
P/B ratio1.82
ROE-28.88%
Payout ratio0.00%
Current ratio7.47
Quick ratio7.40
Cash Ratio5.66

SillaJen Dividend FAQ

Does SillaJen stock pay dividends?
SillaJen does not currently pay dividends to its shareholders.
Has SillaJen ever paid a dividend?
No, SillaJen has no a history of paying dividends to its shareholders. SillaJen is not known for its dividend payments.
Why doesn't SillaJen pay dividends?
There are several potential reasons why SillaJen would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will SillaJen ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While SillaJen has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is SillaJen a dividend aristocrat?
SillaJen is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is SillaJen a dividend king?
SillaJen is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is SillaJen a dividend stock?
No, SillaJen is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy SillaJen stocks?
To buy SillaJen you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy SillaJen stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.